Similar articles for PMID: 24353161

Year	Number of Results
2004	1
2005	3
2006	5
2007	8
2008	3
2009	8
2010	15
2011	25
2012	14
2013	17
2014	28
2015	39
2016	25
2017	35
2018	24
2019	30
2020	35
2021	22
2022	27
2023	5
2024	0

1

Cancer nanomedicine: from drug delivery to imaging.

Chow EK, Ho D. Chow EK, et al. Sci Transl Med. 2013 Dec 18;5(216):216rv4. doi: 10.1126/scitranslmed.3005872. Sci Transl Med. 2013. PMID: 24353161 Review.

2

Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.

Zanganeh S, Spitler R, Hutter G, Ho JQ, Pauliah M, Mahmoudi M. Zanganeh S, et al. Immunotherapy. 2017 Sep;9(10):819-835. doi: 10.2217/imt-2017-0041. Immunotherapy. 2017. PMID: 28877626 Review.

3

Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy.

Liang C, Xu L, Song G, Liu Z. Liang C, et al. Chem Soc Rev. 2016 Nov 7;45(22):6250-6269. doi: 10.1039/c6cs00458j. Chem Soc Rev. 2016. PMID: 27333329 Review.

4

Perspectives and potential applications of nanomedicine in breast and prostate cancer.

Liu Y, Solomon M, Achilefu S. Liu Y, et al. Med Res Rev. 2013 Jan;33(1):3-32. doi: 10.1002/med.20233. Epub 2010 Nov 9. Med Res Rev. 2013. PMID: 23239045 Review.

5

Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.

Bharali DJ, Mousa SA. Bharali DJ, et al. Pharmacol Ther. 2010 Nov;128(2):324-35. doi: 10.1016/j.pharmthera.2010.07.007. Epub 2010 Aug 10. Pharmacol Ther. 2010. PMID: 20705093 Review.

6

Nanodiamond-based chemotherapy and imaging.

Ho D. Ho D. Cancer Treat Res. 2015;166:85-102. doi: 10.1007/978-3-319-16555-4_4. Cancer Treat Res. 2015. PMID: 25895865 Review.

7

Multifunctional nanoparticles for multimodal imaging and theragnosis.

Lee DE, Koo H, Sun IC, Ryu JH, Kim K, Kwon IC. Lee DE, et al. Chem Soc Rev. 2012 Apr 7;41(7):2656-72. doi: 10.1039/c2cs15261d. Epub 2011 Dec 21. Chem Soc Rev. 2012. PMID: 22189429 Review.

8

Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.

Namiki Y, Fuchigami T, Tada N, Kawamura R, Matsunuma S, Kitamoto Y, Nakagawa M. Namiki Y, et al. Acc Chem Res. 2011 Oct 18;44(10):1080-93. doi: 10.1021/ar200011r. Epub 2011 Jul 26. Acc Chem Res. 2011. PMID: 21786832 Review.

9

Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications.

Wicki A, Witzigmann D, Balasubramanian V, Huwyler J. Wicki A, et al. J Control Release. 2015 Feb 28;200:138-57. doi: 10.1016/j.jconrel.2014.12.030. Epub 2014 Dec 26. J Control Release. 2015. PMID: 25545217 Review.

10

Nanomedicine applied to translational oncology: A future perspective on cancer treatment.

Bregoli L, Movia D, Gavigan-Imedio JD, Lysaght J, Reynolds J, Prina-Mello A. Bregoli L, et al. Nanomedicine. 2016 Jan;12(1):81-103. doi: 10.1016/j.nano.2015.08.006. Epub 2015 Sep 12. Nanomedicine. 2016. PMID: 26370707 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

327 results

Results by year